Special issue on women, psychoanalysis, and gender: Editors' introduction.

Introduces this special issue of Psychoanalytic Psychology. This special issue on Women, Psychoanalysis, and Gender is a commemoration of the capability, influence, acceptance, and authority of women in the community of psychoanalysis. In this issue, we turn to both new and more established voices in an expanded arena of gender, culture, and psychoanalysis. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Thoughts on the constructions of maternal representations.

Discusses the deconstructive shift in the conception of mothers and mothering from a unitary category of women in a biological relationship with their offspring to a more fluid constellation of active maternal relations. The author suggests a new parenting subject that transcends gender, constructed through the work of intersubjective dyads. Two questions are addressed: (1) How might the representation of such maternal relationships and their internalization be envisioned? (2) How might a changing conception of internalized maternal representations affect psychoanalytic practice? With reference to J. Bowlby's (1980) concept of internal working models of attachment, and to more recent infant research, the concept of maternal functions (specifically, functions of security, regulation, and recognition) is introduced as central to the mothering relation. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Nanotechnology‐Enabled Closed Loop Insulin Delivery Device: In Vitro and In Vivo Evaluation of Glucose‐Regulated Insulin Release for Diabetes Control

Recently, a new multifunctional, bio‐inorganic nanocomposite membrane with the ability to self‐regulate the release of insulin in response to blood glucose (BG) levels was reported. Herein, the application of this material as part of a small, implantable, closed‐loop insulin delivery device designed to continuously monitor BG concentrations and regulate insulin release is proposed. The insulin delivery device consists of a nanocomposite glucose‐responsive plug covalently bound to an insulin reservoir made of surface‐modified silicone. The plug is prepared with crosslinked bovine serum albumin (BSA) and enzymes (glucose oxidase (GOx) and catalase (CAT)), pH‐responsive hydrogel nanoparticles, and multifunctional MnO₂ nanoparticles. The plug functions both as a glucose sensor and controlled delivery unit to release higher rates of insulin from the reservoir in response to hyperglycemic BG levels and basal insulin rates at normal BG concentration. The surfaces of the device are modified by silanization followed by PEGylation to ensure its safety and biocompatibility and the stability of encased insulin. Our results show that insulin release can be modulated in vitro in response to glucose concentrations. In vivo experiments show that the glycemia of diabetic rats can be controlled with implantation of the prototype device. The glucose‐responsiveness of the device is also demonstrated by rapid drop in BG level after challenging diabetic rats with bolus injection of glucose solution. In addition, it is demonstrated that surface PEGylation of the device is necessary for reducing the immune response of the host to the implanted foreign object and maintaining insulin stability and bioactivity. With this molecular architecture and the bio‐inorganic nanocomposite plug, the device has the ability to maintain normal BG levels in diabetic rats.     

Coenzymes Q in lemon shark liver

Earlier studies have shown that some extracts of nonpolar lipids from lemon shark liver are able to stimulate the reticuloendothelial system (RES) of experimental animals. This communication reports the identification of the coenzymes Q as the constituents of a fraction from lemon shark liver lipid which showed intense biological activity.     

The Distribution of Fatty Acid Biomarkers of Dairy Intake across Serum Lipid Fractions: The Prospective Metabolism and Islet Cell Evaluation (PROMISE) Cohort

Circulating fatty acids (FA) derived largely from dairy consumption have most commonly been measured in total human serum or phospholipid (PL) fractions, and have been used as validated biomarkers of dairy intake in a growing number of epidemiological studies. Nevertheless, measurement and characterization of a wider spectrum of FA biomarkers of dairy across the four major serum lipid fractions is lacking. This study aimed to (1) quantify FA biomarkers of dairy in PL, triacylglycerol (TAG), cholesteryl ester (CE), and unesterified fatty acid (FFA) serum lipid fractions; and (2) identify potential demographic and metabolic factors that may modify the proportions of these FA across serum fractions. Baseline data from 444 adults in the PROMISE cohort were analyzed. FA biomarkers, 15:0, t16:1n-7, 18:2-c9,t11, and t18:1n-7 were quantified from serum. Dairy intake was estimated using the validated Canadian Diet History Questionnaire. Our results show that t18:1n-7 was the most abundant FA biomarker in all fractions except CE, where 18:2-c9,t11 was the most abundant. Positive correlations within fractions, and across FA in the PL, CE, and FFA fractions were found, however, TAG FA were negatively correlated with the other fractions. PL and CE FA were positively associated with dairy intake, and negatively associated with markers of dysmetabolism while, in contrast, these markers were predictors of higher TAG dairy FA. This study is the first to demonstrate distinct proportions of dairy FA in different serum lipid fractions. PL and CE FA marked dairy intake in this cohort, while TAG FA appeared to be markers of dysmetabolism.     

A review of frequency regulation markets in three U.S. ISO/RTOs

A review of the frequency regulation market practices of the ISO New England, PJM Interconnection, and Midcontinent ISO is presented here. Particular attention is given to market structure, resource eligibility, selection, market clearing and settlements. An overview of frequency regulating reserves and the capacity and performance components is provided. We find that the observed spread in historic market clearing prices can be explained by how each operator incorporates lost opportunity cost into their clearing formulation.     

The character to lead: A closer look at character in leadership.

This study explored The Worthy Leadership Model's (Thompson, Grahek, Phillips, & Fay, 2008) “Character to Lead” construct, which encompasses three factors (Personal Integrity and Ethics; Organizational Integrity and Courage; and Humility, Gratitude, and Forgiveness) and nine dimensions (personal integrity, ethics, openness, organizational integrity, courage, power, humility, gratitude, and forgiveness). This article reports the results of an empirical test of the model's character construct using a behavioral measure of character in leadership. The measure (The Worthy Leadership Profile for Executives, WLPe) consisted of self-ratings by director and executive-level leaders (N = 275) along with ratings of these leaders by their managers, direct reports, peers, and others (N = 4,127 raters). Psychometric characteristics of the ratings are reported along with the relationship of ratings of character in leadership to selected personality variables. The article also examines the degree to which managers, peers, and direct reports perceived factors of character (as compared to factors of capacity and commitment) as being important to leaders' roles and to the likelihood of future success and/or failure. Finally, the study explored the degree to which ratings on the character construct were related to employees' perceptions of selected job-related outcomes (past job performance, failure to reach full potential, perceived support for the leadership efforts of others, and overall perceptions of worthy leadership). (PsycINFO Database Record (c) 2010 APA, all rights reserved)